Retatrutide: The Triple-Target Weight Loss Drug That Could Redefine Obesity Treatment
Retatrutide is an investigational triple-agonist weight loss injection targeting GLP-1, GIP, and glucagon receptors simultaneously. Early trials suggest it may outperform current obesity medications, including Wegovy and Mounjaro.